Adam Kenji Koyama Leigh

Lab Manager at Alpine Immune Sciences

Adam Kenji Koyama Leigh has a diverse work experience in the field of biological laboratory management and research. Adam is currently working as a Lab Manager at Alpine Immune Sciences, Inc. since July 2021. Prior to this role, they were a Biological Laboratory Consultant at Georgetown University from August 2019 to November 2021.

Adam also has extensive experience as a Lab Manager 2 at Northwestern University from October 2012 to June 2021. In this role, they were responsible for various tasks such as coordinating with principal investigators, managing wetlab human samples, training and supervising research assistants, generating and organizing immunological data, and handling budget management and purchasing.

Before joining Northwestern University, Adam worked as a Laboratory Technician/Manager at The University of British Columbia from May 2010 to July 2012. Adam also had a research assistant role at The University of British Columbia from May 2009 to December 2009.

Additionally, Adam has experience as a Research Assistant at Kinexus, a co-op position at the University of British Columbia, where they worked on completing customer orders, instructing lab procedures to co-op students and technicians, and collecting and entering data for the Phosphonet database.

Overall, Adam Kenji Koyama Leigh has a strong background in laboratory management, research coordination, and data analysis in the field of biological sciences.

Adam Kenji Koyama Leigh completed their Bachelor of Science degree in Microbiology and Immunology at The University of British Columbia from 2005 to 2010.

Location

Bellevue, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Alpine Immune Sciences

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.


Employees

51-200

Links